Published on in Vol 6, No 2 (2017): February

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

Val Gebski   1 , MStat ;   Emma Gibbs   2 , MSc ;   Mihir Gandhi   3 , MSc ;   Gilles Chatellier   4 , PhD ;   Aurelia Dinut   4 , PhD ;   Helena Pereira   4 , MSc ;   Pierce KH Chow   5 , PhD ;   Valérie Vilgrain   6 , PhD

1 NHMRC Clinical Trials Centre, University Sydney, Camperdown, Australia

2 NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia

3 Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore

4 Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France

5 Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore

6 Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris, France

Corresponding Author:

  • Val Gebski, MStat
  • NHMRC Clinical Trials Centre
  • University Sydney
  • Level 5 MFB Building
  • 92-94 Parramatta Road
  • Camperdown, 2050
  • Australia
  • Phone: 61 2 9562 5328
  • Fax: 61 2 9565 1863
  • Email: val@ctc.usyd.edu.au